Arcturus Therapeutics (ARCT) shares jumped in the last session on above-average trading volume, but the current momentum is unlikely to persist as earnings-estimate revisions may not drive additional gains in the near term.
Arcturus Therapeutics (ARCT) shares jumped in the last session on above-average trading volume, but the current momentum is unlikely to persist as earnings-estimate revisions may not drive additional gains in the near term.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.10
Ticker Sentiment
